000 | 01877 a2200517 4500 | ||
---|---|---|---|
005 | 20250516024718.0 | ||
264 | 0 | _c20110505 | |
008 | 201105s 0 0 rus d | ||
022 | _a1997-7298 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBisaga, G N | |
245 | 0 | 0 |
_a[Possibilities of treatment of multiple sclerosis exacerbations without corticosteroids: a role of metabolic and antioxidant therapy]. _h[electronic resource] |
260 |
_bZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova _c2011 |
||
300 |
_a44-8 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntioxidants _xtherapeutic use |
650 | 0 | 4 |
_aAutoantibodies _xblood |
650 | 0 | 4 | _aCognition |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFlavin Mononucleotide _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInosine Diphosphate _xtherapeutic use |
650 | 0 | 4 | _aLipid Peroxidation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethylprednisolone _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMultiple Sclerosis, Chronic Progressive _xdrug therapy |
650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
650 | 0 | 4 |
_aMyelin Sheath _ximmunology |
650 | 0 | 4 |
_aNiacinamide _xtherapeutic use |
650 | 0 | 4 |
_aPentoxifylline _xtherapeutic use |
650 | 0 | 4 |
_aSuccinates _xtherapeutic use |
650 | 0 | 4 |
_aVitamin B Complex _xtherapeutic use |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aOdinak, M M | |
700 | 1 | _aBoĭko, A N | |
700 | 1 | _aMel'nik, Iu B | |
700 | 1 | _aPopova, N F | |
773 | 0 |
_tZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova _gvol. 111 _gno. 2 _gp. 44-8 |
|
999 |
_c20625818 _d20625818 |